A detailed history of Cornerstone Planning Group LLC transactions in Bio Rad Laboratories, Inc. stock. As of the latest transaction made, Cornerstone Planning Group LLC holds 32 shares of BIO stock, worth $8,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
32
Previous 26 23.08%
Holding current value
$8,862
Previous $8.4 Million 6.67%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 07, 2024

BUY
$304.11 - $351.99 $1,824 - $2,111
6 Added 23.08%
32 $8.96 Million
Q4 2023

Feb 12, 2024

SELL
$269.37 - $365.04 $269 - $365
-1 Reduced 3.7%
26 $8.4 Million
Q3 2023

Nov 08, 2023

SELL
$350.25 - $422.63 $1,751 - $2,113
-5 Reduced 15.63%
27 $9.68 Million
Q2 2023

Aug 15, 2023

BUY
$359.49 - $486.4 $6,111 - $8,268
17 Added 113.33%
32 $12.1 Million
Q4 2022

Feb 14, 2023

BUY
$351.71 - $456.01 $5,275 - $6,840
15 New
15 $6.76 Million

Others Institutions Holding BIO

About BIO-RAD LABORATORIES, INC.


  • Ticker BIO
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 24,633,900
  • Market Cap $6.82B
  • Description
  • Bio-Rad Laboratories, Inc. manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, an...
More about BIO
Track This Portfolio

Track Cornerstone Planning Group LLC Portfolio

Follow Cornerstone Planning Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cornerstone Planning Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cornerstone Planning Group LLC with notifications on news.